Function and inhibition of intracellular calcium-independent phospholipase A2.
about
Neurodegeneration with brain iron accumulation: update on pathogenic mechanismsThe molecular basis of phosphatidylcholine preference of human group-V phospholipase A2VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionMaintenance of synaptic stability requires calcium-independent phospholipase A₂ activityMultiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activityHuman Pancreatic Islets Express mRNA Species Encoding Two Distinct Catalytically Active Isoforms of Group VI Phospholipase A2 (iPLA2) [etc.]Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cellsHuman group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophilsGroup V phospholipase A2 induces leukotriene biosynthesis in human neutrophils through the activation of group IVA phospholipase A2The role of phospholipases A2 in schizophreniaNegative regulation of cytosolic phospholipase A(2) by melatonin in the rat pineal glandCa(2+) influx in the endothelial cells is required for the bradykinin-induced endothelium-dependent contraction in the porcine interlobar renal arteryP2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acidA novel group of phospholipase A2s preferentially expressed in type 2 helper T cellsCa2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entryPostsynaptic injection of calcium-independent phospholipase A2 inhibitors selectively increases AMPA receptor-mediated synaptic transmissionClozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy.Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.Phospholipase A2: its usefulness in laboratory diagnostics.Regulation and metabolism of arachidonic acid.Phospholipase A2 enzymes in eicosanoid generation.Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.Phospholipase A2 in eicosanoid generation.Signal transduction mechanisms and behavioral sensitization to stimulant drugs: an overview of cAMP and PLA2.Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2.Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPKThe MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.Insulin resistance in HIV protease inhibitor-associated diabetes.Group VIB calcium-independent phospholipase A2 (iPLA2γ) regulates platelet activation, hemostasis and thrombosis in mice.The role of calcium-independent phospholipase A2γ in modulation of aqueous humor drainage and Ca2+ sensitization of trabecular meshwork contraction.Calcium-independent phospholipases A2 and their roles in biological processes and diseases.Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis.Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2.Smooth muscle-specific expression of calcium-independent phospholipase A2β (iPLA2β) participates in the initiation and early progression of vascular inflammation and neointima formationGroup VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells.Cytosolic phospholipase A2 gamma is involved in hepatitis C virus replication and assemblySynthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes.
P2860
Q21129274-59FE7FCE-C5B1-4810-8F57-1C6B129B5086Q24532066-21B696D3-ABC8-407A-BCE8-82C6BC88821AQ24673566-27C721E6-473A-4532-AA8A-61C9CB7C4CF0Q26997377-BE375889-5660-41B2-B089-0258244BE0CCQ27027705-6CFF4E1A-EC4D-4701-B6CE-F74EC73F2E5CQ28118381-376464EE-A929-47C7-BAFD-AD7F08F895F2Q28139679-B0607C04-8196-40E1-B3B3-8DF942A2483CQ28146023-0525F5E5-7905-48EE-B07B-115352153DF0Q28177949-E36FBD6E-2C4B-47A0-87BE-71B807882D04Q28215075-00F8346B-F033-405C-AEE9-B540AC5DCB84Q28305324-B5825D46-9145-4B4F-9A5C-2C7CA0FA9475Q28344878-A35B7AC2-264B-4ED0-9278-631BE668F8BBQ28345135-AB1EE9B7-9DFA-40DD-AF5E-F9DA985858E7Q28512950-B1D51156-CCB0-4E66-8556-0D1F8FB65670Q28513976-1B3E748D-CF4C-46A7-9833-1DEC875FDC85Q28570957-0CC6DDC7-CF52-4ED8-B81F-A1C5CF73EC85Q28574265-F9659274-1827-4CED-9114-192C3F529ED3Q31832226-8407FE4B-D28D-45E3-BF66-D3C7436CA96FQ33595339-D702D5AE-1EB5-4910-962B-F3935CF39204Q33702391-EBF249C8-12DF-4B7B-AB13-8968F017E618Q33705458-3EBF6271-E2D6-432D-A1D5-97D9233E8711Q33790580-A53BFD26-9D5D-4D1D-9C80-F28C37E85629Q33833653-B07911D1-D873-4AC5-B20A-F4378A9D1685Q33836689-44008892-6134-438E-A983-232A154CC182Q34420274-2DAA4309-034B-49A0-9DFC-9EC7D6597382Q34756757-DE288E92-A85A-4981-BE85-CB4DEB8DC344Q35028614-B5A1C519-34E3-4D78-AB76-574221CF10F0Q35042474-343B6F9E-C980-458C-9834-B7E6FA02556EQ35237635-E348E5E4-4D07-481C-B3D2-035AE1259637Q35330471-488E1FF8-017E-4CFC-AA10-4366502F121BQ35900703-0124974E-91F8-4458-B2E9-E6CC9E167F47Q35994344-85DA10E5-7A72-478B-9C20-FB3DB7103486Q36097167-E27E8863-3060-4707-A9C4-98D5BD5340A5Q36097195-233488CB-FF83-47EA-AD24-E31F9D4ED260Q36098088-3D1F1FC2-216E-43F7-B8DD-01248F5437A1Q36174271-E46499D6-F5B2-4F4D-ACCB-2F1C26F5019FQ36269130-F8501CC5-E254-40B0-BAC4-0083ADDC6172Q36302173-101BCA90-DD41-420B-AE10-EEFA24412D78Q36397553-F6626AC5-4B23-4893-B0C7-846B4C83F856Q37112089-AEF5AB95-31B6-4464-A5DB-63F1B81284C7
P2860
Function and inhibition of intracellular calcium-independent phospholipase A2.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Function and inhibition of intracellular calcium-independent phospholipase A2.
@en
type
label
Function and inhibition of intracellular calcium-independent phospholipase A2.
@en
prefLabel
Function and inhibition of intracellular calcium-independent phospholipase A2.
@en
P356
P1476
Function and inhibition of intracellular calcium-independent phospholipase A2.
@en
P2093
E A Dennis
P304
16069-16072
P356
10.1074/JBC.272.26.16069
P407
P577
1997-06-01T00:00:00Z